We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
-4.37%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$728M
AUM Growth
+$39.8M
Cap. Flow
+$72.6M
Cap. Flow %
9.97%
Top 10 Hldgs %
61.41%
Holding
141
New
8
Increased
69
Reduced
37
Closed
19
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PXH icon
101
Invesco FTSE RAFI Emerging Markets ETF
PXH
$2.01B
$296K 0.04%
+14,239
New +$310K
META icon
102
Meta Platforms (Facebook)
META
$1.47T
$275K 0.04%
1,237
+43
+4% +$10.7K
BX icon
103
Blackstone
BX
$107B
$270K 0.04%
2,124
+52
+3% +$6.34K
RTX icon
104
RTX Corp
RTX
$285B
$264K 0.04%
2,668
-1,095
-29% -$104K
TLTD icon
105
Northern Trust Morningstar Developed Markets ex-US Factor Tilt ETF
TLTD
$690M
$260K 0.04%
3,816
+7
+0.2% +$485
PFE icon
106
Pfizer
PFE
$159B
$248K 0.03%
4,792
+265
+6% +$13.8K
CRM icon
107
Salesforce
CRM
$211B
$244K 0.03%
1,150
+49
+4% +$10.5K
PANW icon
108
Palo Alto Networks
PANW
$303B
$240K 0.03%
2,310
JNJ icon
109
Johnson & Johnson
JNJ
$646B
$232K 0.03%
1,310
-432
-25% -$73.5K
NEE icon
110
NextEra Energy
NEE
$171B
$232K 0.03%
2,744
+143
+5% +$11.5K
BAC icon
111
Bank of America
BAC
$436B
$231K 0.03%
5,609
-2,567
-31% -$116K
LOW icon
112
Lowe's Companies
LOW
$117B
$231K 0.03%
1,143
-152
-12% -$35K
NVO
113
Novo Nordisk
NVO
$202B
$230K 0.03%
4,136
MKC icon
114
McCormick & Company Non-Voting
MKC
$14.9B
$225K 0.03%
2,256
TMO icon
115
Thermo Fisher Scientific
TMO
$230B
$224K 0.03%
380
+22
+6% +$12.6K
CAT icon
116
Caterpillar
CAT
$368B
$222K 0.03%
+995
New +$209K
IWR icon
117
iShares Russell Mid-Cap ETF
IWR
$57.1B
$221K 0.03%
2,836
HON icon
118
Honeywell
HON
$68.9B
$209K 0.03%
1,138
-438
-28% -$81.1K
NKE icon
119
Nike
NKE
$58.7B
$209K 0.03%
1,557
+114
+8% +$16K
PM icon
120
Philip Morris
PM
$299B
$208K 0.03%
2,218
+92
+4% +$9.2K
ADBE icon
121
Adobe
ADBE
$116B
$207K 0.03%
455
-115
-20% -$55.3K
ABT icon
122
Abbott
ABT
$195B
-1,670
Closed -$235K
BABA icon
123
Alibaba
BABA
$296B
-3,682
Closed -$437K
COIN icon
124
Coinbase
COIN
$47.1B
-1,000
Closed -$252K
CSCO icon
125
Cisco
CSCO
$433B
-4,206
Closed -$267K

Similar funds

Callan Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Callan Capital held 141 positions worth $728M, up 5.8% from $688M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Callan Capital deployed $72.6M of net new capital in Q1 2022, opening 8 new positions and adding to 69 existing holdings. Its largest new stake was Vanguard FTSE Developed Markets ETF: 154,638 shares worth $7.43M.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, an estimated $22.9M trimmed.

  • Callan Capital's largest Q1 2022 buy was Vanguard FTSE Developed Markets ETF: 154,638 shares worth $7.43M.
  • Callan Capital added most to Avantis International Small Cap Value ETF in Q1 2022, an estimated $34.8M increase.
  • Callan Capital's biggest Q1 2022 reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, cutting an estimated $22.9M.
  • Callan Capital fully exited Alibaba in Q1 2022, selling an estimated $437K.
  • Callan Capital's ten largest holdings make up 61% of its $728M portfolio in Q1 2022.
  • Callan Capital opened 8 new positions and closed 19 in Q1 2022.
  • Callan Capital's portfolio value rose 5.8% quarter-over-quarter to $728M.

Based on Callan Capital's 13F filing for Q1 2022, filed 10 May 2022.